Chemours Statistics
Share Statistics
Chemours has 149.41M shares outstanding. The number of shares has increased by 0.81% in one year.
| Shares Outstanding | 149.41M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.25% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 148.33M |
| Failed to Deliver (FTD) Shares | 45 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 7.70M, so 5.16% of the outstanding shares have been sold short.
| Short Interest | 7.70M |
| Short % of Shares Out | 5.16% |
| Short % of Float | 5.2% |
| Short Ratio (days to cover) | 5.37 |
Valuation Ratios
The PE ratio is -19.73 and the forward PE ratio is 8.35.
| PE Ratio | -19.73 |
| Forward PE | 8.35 |
| PS Ratio | 0.78 |
| Forward PS | 0.5 |
| PB Ratio | 6.37 |
| P/FCF Ratio | 25.25 |
| PEG Ratio | n/a |
Enterprise Valuation
Chemours has an Enterprise Value (EV) of 7.19B.
| EV / Earnings | -30.2 |
| EV / Sales | 1.19 |
| EV / EBITDA | 36.49 |
| EV / EBIT | -78.14 |
| EV / FCF | 38.65 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 5.42.
| Current Ratio | 1.54 |
| Quick Ratio | 1 |
| Debt / Equity | 5.42 |
| Total Debt / Capitalization | 84.42 |
| Cash Flow / Debt | 0.14 |
| Interest Coverage | -0.44 |
Financial Efficiency
Return on equity (ROE) is -0.32% and return on capital (ROIC) is -1.36%.
| Return on Equity (ROE) | -0.32% |
| Return on Assets (ROA) | -0.03% |
| Return on Capital (ROIC) | -1.36% |
| Revenue Per Employee | 972.10K |
| Profits Per Employee | -38.39K |
| Employee Count | 6.20K |
| Asset Turnover | 0.73 |
| Inventory Turnover | 3.49 |
Taxes
| Income Tax | -81.00M |
| Effective Tax Rate | 0.25 |
Stock Price Statistics
The stock price has increased by -37.25% in the last 52 weeks. The beta is 1.75, so Chemours's price volatility has been higher than the market average.
| Beta | 1.75 |
| 52-Week Price Change | -37.25% |
| 50-Day Moving Average | 19.88 |
| 200-Day Moving Average | 22.64 |
| Relative Strength Index (RSI) | 40.78 |
| Average Volume (20 Days) | 1.65M |
Income Statement
In the last 12 months, Chemours had revenue of $6.03B and earned -$238.00M in profits. Earnings per share was $-1.6.
| Revenue | 6.03B |
| Gross Profit | 1.31B |
| Operating Income | -92.00M |
| Net Income | -238.00M |
| EBITDA | 197.00M |
| EBIT | -92.00M |
| Earnings Per Share (EPS) | -1.6 |
Balance Sheet
The company has $1.20B in cash and $4.30B in debt, giving a net cash position of -$3.10B.
| Cash & Cash Equivalents | 1.20B |
| Total Debt | 4.30B |
| Net Cash | -3.10B |
| Retained Earnings | 1.78B |
| Total Assets | 7.46B |
| Working Capital | 1.30B |
Cash Flow
In the last 12 months, operating cash flow was $556.00M and capital expenditures -$370.00M, giving a free cash flow of $186.00M.
| Operating Cash Flow | 556.00M |
| Capital Expenditures | -370.00M |
| Free Cash Flow | 186.00M |
| FCF Per Share | 1.25 |
Margins
Gross margin is 21.67%, with operating and profit margins of -1.53% and -3.95%.
| Gross Margin | 21.67% |
| Operating Margin | -1.53% |
| Pretax Margin | -5.28% |
| Profit Margin | -3.95% |
| EBITDA Margin | 3.27% |
| EBIT Margin | -1.53% |
| FCF Margin | 3.09% |
Dividends & Yields
CC pays an annual dividend of $1, which amounts to a dividend yield of 5.15%.
| Dividend Per Share | $1.00 |
| Dividend Yield | 5.15% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 200% |
| Earnings Yield | -8.38% |
| FCF Yield | 6.52% |
Analyst Forecast
The average price target for CC is $25, which is 30.9% higher than the current price. The consensus rating is "Hold".
| Price Target | $25 |
| Price Target Difference | 30.9% |
| Analyst Consensus | Hold |
| Analyst Count | 8 |
Scores
| Altman Z-Score | 1.69 |
| Piotroski F-Score | 4 |